TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search

BAYRY

Bayer AG PK

OTCQXCommon Stock
$15.19
+16.31%today

No SEC filings for this security

Bayer AG PK is a foreign or OTC-listed security (OTCQX) that doesn't file with the SEC, so the grounded research view — financials, filings, insider activity and the call — isn't available. Price and news only.

Key stats

52-week range$7.23 – $15.19
7.2352-week15.19
Market cap
$59.7B
Volume
281K
1Y return
+93.59%
Beta
0.83

Price · 1Y

$15.19▲ +93.59%
over 1Y
L $7.23H $15.19

Recent news

market news →
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)Bullish
finance.yahoo.com· 2026-07-03
Bayer's new unit for Roundup business sparks breakup speculation; Deutsche Bank raises to BuyBullish
seekingalpha.com· 2026-07-02
NVS Gains EC Approval for SMA Therapy Itvisma in Broad PopulationBullish
finance.yahoo.com· 2026-07-02
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at WalmartBullish
finance.yahoo.com· 2026-07-02
Bayer announces consolidation of U.S. glyphosate business into newly formed 'Ruveon LLC'Bullish
seekingalpha.com· 2026-07-02
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as RuveonBullish
finance.yahoo.com· 2026-07-01
Notable healthcare headlines for the week: Merck, AbbVie, and Bayer in focusBullish
seekingalpha.com· 2026-06-28
Bayer's stock surges 24% as SCOTUS wipes out 65,000 Roundup cancer lawsuits — and consumer protections with themBullish
finance.yahoo.com· 2026-06-26

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.